Trial Profile
To study the Efficacy of Fixed Triple Combination Therapy (perindopril/indapamide/amlodipine) in hypertensive patients in Routine Clinical Practice
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Jul 2018
Price :
$35
*
At a glance
- Drugs Amlodipine/indapamide/perindopril (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 28 Jul 2018 New trial record
- 11 Jun 2018 Results presented at the 28th European Meeting on Hypertension and Cardiovascular Protection